Arachnoid Cysts Market Research Report – Forecast to 2027

Global Arachnoid Cysts Research Report: By Type (Intracranial & Spinal), by Diagnosis (CT Scan, MRI Scan, Prenatal Ultrasound, Other Tests), by Treatment (Permanent Drainage System Surgery, Fenestration, Endoscopic Cyst Fenestration)—Forecast till 2027

ID: MRFR/MED/5089-HCR | | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global arachnoid cysts market is expected to grow slowly over the forecast period. It is estimated that the global arachnoid cysts market is expected to steadily grow during the forecast period of 2018–2023. Arachnoid cysts are a type of brain cyst cause between the split of the arachnoid membrane, which is one of the 3 layers of the tissue that covers the brain and the spinal cord.


Rising number of patients suffering from meningitis, tumors and head injuries are expected to drive the growth of the market. According to a report published by the American Society of Clinical Oncology in November 2017, an estimated 23,880 people are expected to be diagnosed with brain and spinal cord tumors in 2017.


Moreover, favorable healthcare expenditures boost the growth of the market. However, lack of knowledge may hamper the market growth during the assessment period.


Segmentation


The global arachnoid cysts market has been segmented into type, diagnosis, and treatment.


The market, on the basis of type, has been segmented into, intracranial and spinal. Intracranial arachnoid cysts are expected to hold the largest market share because of high incidences of the type. Spinal arachnoid cysts are expected to grow at the fastest CAGR owing to rising cases of spinal injuries resulting in cysts.


The market, by diagnosis, has been segmented into, CT scan, MRI scan, prenatal ultrasound, and other tests.


The market, by treatment, has been segmented into, permanent drainage system surgery, fenestration, and endoscopic cyst fenestration.


The market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The arachnoid cysts market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European arachnoid cysts market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The arachnoid cysts market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The arachnoid cysts market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Spiegelberg GmbH & Co. KG ., Sophysa, Aesculap, Inc., DePuy Synthes, Medtronic, Integra LifeSciences, Christoph Miethke GmbH & Co. KG, Tokibo Co. Ltd., Boston Neurosciences, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Hitachi Medical Systems Europe, Siemens Healthcare Private Limited and FUJIFILM SonoSite, Inc. are some of the key players in the global arachnoid cysts market.


Regional Market Summary


Global Arachnoid Cysts Market Share (%), by Region, 2017


Arachnoid Cysts Market Share


Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)


Geographically, the Americas is anticipated to dominate the global arachnoid cysts market owing to technological advancements and rising prevalence of tumor & meningitis. According to a report published by American Society of Clinical Oncology in November 2017, about 3,560 children are expected to be diagnosed with a brain tumor or CNS tumor in 2017.


Europe is expected to hold the second largest position in the global arachnoid cysts market. The market growth in this region is attributed to the growing prevalence of spinal cord & brain tumors and increasing healthcare expenditure. According to Cancer Research UK, 11,432 new cases of brain tumors were reported in 2015 in the UK.


Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising awareness of tumors & meningitis and government support for healthcare facilities. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cases of cancer in China in 2015.


On the other hand, the Middle East & Africa has the least market share. Majority of the market of this region is expected to be held by the Middle East region due to growing government initiatives for the improvement of the healthcare sector.


Global Arachnoid Cysts Market, by Type



  • Intracranial

  • Spinal


Global Arachnoid Cysts Market, by Diagnosis



  • CT Scan

  • MRI Scan

  • Prenatal Ultrasound

  • Other Tests


Global Arachnoid cysts Market, by Treatment



  • Permanent Drainage System Surgery

  • Fenestration

  • Endoscopic Cyst Fenestration


Global Arachnoid Cysts Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific



  • Middle East & Africa



  • Middle East

  • Africa


Intended Audience



  • Shunt Valves Manufacturers

  • Medical Devices Suppliers & Manufacturers

  • Research and Development (R&D) Companies

  • Government and Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Academic Medical Institutes and Universities



Frequently Asked Questions (FAQ) :


Lack of knowledge may hamper the arachnoid cysts market.

The diagnosis part of arachnoid cysts market has CT scan, MRI scan, prenatal ultrasound, and other tests.

The Americas would top the arachnoid cysts market.

The fastest-growing regional arachnoid cysts market would be Asia Pacific.

Arachnoid cysts market in Europe would benefit from increasing spinal cord and brain tumor studies, along with high healthcare expenditures.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Arachnoid Cysts Market, by Type

6.1 Introduction

6.2 Intracranial

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Spinal

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Arachnoid Cysts Market, by Diagnosis

7.1 Introduction

7.2 CT Scan

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 MRI Scan

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Prenatal Ultrasound

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Other Tests

Chapter 8. Global Arachnoid Cysts Market, by Treatment

8.1 Introduction

8.2 Permanent drainage system surgery

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Fenestration

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Endoscopic Cyst Fenestration

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Arachnoid Cysts Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Spiegelberg GmbH & Co. KG .

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Sophysa

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Aesculap, Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 DePuy Synthes

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Medtronic

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Integra LifeSciences

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Christoph Miethke GmbH & Co. KG

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Tokibo Co. Ltd.

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Boston Neurosciences

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Koninklijke Philips N.V.

11.10.1 Company Overview

11.10.2 Product Overview

11.10.3 Financial Overview

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 GENERAL ELECTRIC COMPANY

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Hitachi Medical Systems Europe

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Siemens Healthcare Private Limited

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 FUJIFILM SonoSite, Inc.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Arachnoid Cysts Industry

Chapter 13. Appendix


LIST OF TABLES

Table 1 Global Arachnoid Cysts Market Synopsis, 2020-2027

Table 2 Global Arachnoid Cysts Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Arachnoid Cysts Market, by Region, 2020-2027 (USD Million)

Table 4 Global Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 5 Global Arachnoid Cysts Market, by Diagnosis, 2020-2027(USD Million)

Table 6 Global Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 7 North America: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 8 North America: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 9 North America: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 10 US: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 11 US: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 12 US: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 13 Canada: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 14 Canada: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 15 Canada: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 16 South America: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 17 South America: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 18 South America: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 19 Europe: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 20 Europe: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 21 Europe: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 22 Western Europe: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 23 Western Europe: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 24 Western Europe: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD

Million)

Table 25 Eastern Europe: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 26 Eastern Europe: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 27 Eastern Europe: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)

Table 33 Middle East & Africa: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD

Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Arachnoid Cysts Market

Figure 3 Segmentation Market Dynamics for Global Arachnoid Cysts Market

Figure 4 Global Arachnoid Cysts Market Share, by Type, 2020

Figure 5 Global Arachnoid Cysts Market Share, by Diagnosis, 2020

Figure 6 Global Arachnoid Cysts Market Share, by Treatment, 2020

Figure 7 Global Arachnoid Cysts Market Share, by Region, 2020

Figure 8 North America: Arachnoid Cysts Market Share, by Country, 2020

Figure 9 Europe: Arachnoid Cysts Market Share, by Country, 2020

Figure 10 Asia-Pacific: Arachnoid Cysts Market Share, by Country, 2020

Figure 11 Middle East & Africa: Arachnoid Cysts Market Share, by Country, 2020

Figure 12 Global Arachnoid Cysts Market: Company Share Analysis, 2020 (%)

Figure 13 Spiegelberg GmbH & Co. KG .: Key Financials

Figure 14 Spiegelberg GmbH & Co. KG .: Segmental Revenue

Figure 15 Spiegelberg GmbH & Co. KG .: Geographical Revenue

Figure 16 Sophysa: Key Financials

Figure 17 Sophysa: Segmental Revenue

Figure 18 Sophysa: Geographical Revenue

Figure 19 Aesculap, Inc.: Key Financials

Figure 20 Aesculap, Inc.: Segmental Revenue

Figure 21 Aesculap, Inc.: Geographical Revenue

Figure 22 DePuy Synthes: Key Financials

Figure 23 DePuy Synthes: Segmental Revenue

Figure 24 DePuy Synthes: Geographical Revenue

Figure 25 Medtronic: Key Financials

Figure 26 Medtronic: Segmental Revenue

Figure 27 Medtronic: Geographical Revenue

Figure 28 Integra LifeSciences: Key Financials

Figure 29 Integra LifeSciences: Segmental Revenue

Figure 30 Integra LifeSciences: Geographical Revenue

Figure 31 Christoph Miethke GmbH & Co. KG: Key Financials

Figure 32 Christoph Miethke GmbH & Co. KG: Segmental Revenue

Figure 33 Christoph Miethke GmbH & Co. KG: Geographical Revenue

Figure 34 Tokibo Co. Ltd.: Financials

Figure 35 Tokibo Co. Ltd.: Segmental Revenue

Figure 36 Tokibo Co. Ltd.: Geographical Revenue

Figure 37 Boston Neurosciences: Key Financials

Figure 38 Boston Neurosciences: Segmental Revenue

Figure 39 Boston Neurosciences: Geographical Revenue

Figure 40 Koninklijke Philips N.V.: Key Financials

Figure 41 Koninklijke Philips N.V.: Segmental Revenue

Figure 42 Koninklijke Philips N.V.: Geographical Revenue

Figure 43 GENERAL ELECTRIC COMPANY: Key Financials

Figure 44 GENERAL ELECTRIC COMPANY: Segmental Revenue

Figure 45 GENERAL ELECTRIC COMPANY: Geographical Revenue

Figure 46 Hitachi Medical Systems Europe: Key Financials

Figure 47 Hitachi Medical Systems Europe: Segmental Revenue

Figure 48 Hitachi Medical Systems Europe: Geographical Revenue

Figure 49 Siemens Healthcare Private Limited: Financials

Figure 50 Siemens Healthcare Private Limited: Segmental Revenue

Figure 51 Siemens Healthcare Private Limited: Geographical Revenue

Figure 52 FUJIFILM SonoSite, Inc.: Key Financials

Figure 53 FUJIFILM SonoSite, Inc.: Segmental Revenue

Figure 54 FUJIFILM SonoSite, Inc.: Geographical Revenue